Guardant Health, Inc.
GH
$161.99
$9.646.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.74% | 39.56% | 32.88% | 30.38% | 28.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.74% | 39.56% | 32.88% | 30.38% | 28.74% |
| Cost of Revenue | 34.39% | 26.73% | 20.43% | 19.07% | 19.45% |
| Gross Profit | 47.68% | 47.65% | 40.91% | 37.82% | 34.95% |
| SG&A Expenses | 38.33% | 35.69% | 29.61% | 30.24% | 34.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.24% | 24.42% | 20.03% | 19.62% | 20.25% |
| Operating Income | -2.09% | 1.43% | 1.42% | -2.35% | -7.46% |
| Income Before Tax | -10.11% | -4.57% | 4.03% | 22.40% | 15.81% |
| Income Tax Expenses | -196.28% | -201.03% | -198.36% | 4,270.37% | 120.53% |
| Earnings from Continuing Operations | -9.57% | -4.00% | 4.61% | 22.17% | 15.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.57% | -4.00% | 4.61% | 22.17% | 15.68% |
| EBIT | -2.09% | 1.43% | 1.42% | -2.35% | -7.46% |
| EBITDA | -2.98% | 0.85% | 0.91% | -3.29% | -8.80% |
| EPS Basic | -4.60% | -0.63% | 6.77% | 24.16% | 18.24% |
| Normalized Basic EPS | 0.49% | 0.44% | -3.31% | -5.90% | -9.70% |
| EPS Diluted | -4.60% | -0.63% | 6.77% | 24.16% | 18.24% |
| Normalized Diluted EPS | 0.49% | 0.44% | -3.31% | -5.90% | -9.70% |
| Average Basic Shares Outstanding | 4.61% | 3.19% | 2.14% | 2.23% | 2.99% |
| Average Diluted Shares Outstanding | 4.61% | 3.19% | 2.14% | 2.23% | 2.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |